Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Cell Based Assays Market Be Worth By 2029?
The market size for cell-based assays has markedly expanded in the past few years. The projections show an increase from $27.07 billion in 2024 to $29.41 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The significant growth in the historic period has been driven by the advent of HTS techniques, the incorporation of automation, the application of biomarker detection, the use of microfluidics, and the introduction of gene editing tools.
In the coming years, the market size for cell-based assays is predicted to experience a significant surge, escalating to a value of $48.18 billion by 2029. This equates to a compound annual growth rate (CAGR) of 13.1%. Factors contributing to this boom during the forecast period include the implementation of AI and machine learning, alterations in the regulatory environment, an increased need for high-content screening, improvement in disease modeling, and a concentrated focus on precision medicine. Some major upcoming trends in this forecast period encompass high-throughput screening (HTA), the utilization of 3d cell cultures, the organ-on-a-chip technology, the CRISPR/cas9 technology and advancements in imaging techniques.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2546&type=smp
What External And Internal Drivers Are Influencing The Cell Based Assays Market?
Evolutionary strides in research utilizing cell-based arrays have emphasized the essential shift towards more predictive cellular models in drug discovery in order to tactically combat late-stage failures of drugs. The pressure on pharmaceutical industry to gain efficiency in drug commercialization to mitigate the severe financial impact of late-stage failures aligns directly with the drive for innovation in cell-based assays. The fallout from investigational new drug (IND) Phase III clinical trials’ failures can cost companies hundreds of millions of dollars. As an illustration, a Sigma report indicates that the return on their investment may dwindle down to a mere 5% for pharmaceutical firms due to the current rate of late-stage failures, a percentage companies find intolerably low. Key advancements in high-content systems and data decoding drawn from cell-based assays are empowering scientists with increased knowledge about cellular responses. This knowledge aids strategic decision-making during drug discovery, thereby further fuelling the growth of the cell-based array market.
What Segmentation Insights Are Provided In The Cell Based Assays Market Research?
The cell based assaysmarket covered in this report is segmented –
1) By Product And Service: Consumables; Instruments; Services; Software
2) By Technology: Automated Handling; Flow Cytometry; Label-Free Detection; High-Throughput Screening; Other Technologies
3) By Application: Drug Discovery; Basic Research; Adme Studies; Predictive Toxicology; Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Government Research Institutes; Contract Research Organizations (CRO); Other End Users
Subsegments:
1) By Consumables: Cell Culture Media; Reagents And Kits; Cell Lines; Microplates
2) By Instruments: Microplate Readers; Flow Cytometers; Cell Imaging Systems; Automated Cell Culture Systems
3) By Services: Custom Assay Development; Contract Research Services; Training And Consulting Services
4) By Software: Data Analysis Software; Lab Management Software; Simulation And Modeling Software
Which Trends Are Likely To Redefine Growth Paths In The Cell Based Assays Market?
The tendency of research scientists is towards preliminary predictive toxicity testing, an effort aimed at obstructing failures of drugs at advanced stages. The upscaling of predictive cell toxicity assays is being pursued to enhance compounds’ screening during the early periods of drug development, thus shrinking failure costs. Take, for instance, Creative Bioarray, a biotech organization offers a myriad of in vitro toxicity solutions to evaluate drug-induced toxicities, thereby saving both resources and time by diminishing the likelihood of failings at the initial stages. This progress will simplify clinical trials and decrease the operational costs.
Who Are The Leading Companies Driving The Cell Based Assays Market?
Major companies operating in the cell based assays market include F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Miltenyi Biotec GmbH, Abcam plc, BioVision Inc., Promega Corporation, Cell Signaling Technology Inc., BioTek Instruments Inc., Enzo Life Sciences Inc., BioAgilytix Labs LLC, Cisbio International LLC, ProQinase GmbH, QGel SA, Biotium Inc., Selexis SA, Aurelia Bioscience Ltd., Creative Bioarray, Cell Biolabs Inc., Essen BioScience Ltd., Eurofins Scientific SE, DiscoveRx Corporation
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Cell Based Assays Market?
North America was the largest region in the cell-based assays market in 2024. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=2546&type=smp
Browse Through More Reports Similar to the Global Cell Based Assays Market 2025, By The Business Research Company
Cell Culture Consumables And Equipment Global Market Report 2025
Cell Therapy Technologies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Cell And Genes Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model